TNSN88025A1 - 4-[4-[4-[4-[[2-(2,4 - difluorophenyl)-2-(1h-azolymethyl) - 1,3 - dioxolanne -4- yl] methoxy phenyl] -1- piperazinyl] phenyl] triazolones. - Google Patents
4-[4-[4-[4-[[2-(2,4 - difluorophenyl)-2-(1h-azolymethyl) - 1,3 - dioxolanne -4- yl] methoxy phenyl] -1- piperazinyl] phenyl] triazolones.Info
- Publication number
- TNSN88025A1 TNSN88025A1 TNTNSN88025A TNSN88025A TNSN88025A1 TN SN88025 A1 TNSN88025 A1 TN SN88025A1 TN TNSN88025 A TNTNSN88025 A TN TNSN88025A TN SN88025 A TNSN88025 A TN SN88025A TN SN88025 A1 TNSN88025 A1 TN SN88025A1
- Authority
- TN
- Tunisia
- Prior art keywords
- phenyl
- dioxolanne
- triazolones
- difluorophenyl
- piperazinyl
- Prior art date
Links
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title abstract 4
- -1 2,4 - DIFLUOROPHENYL Chemical class 0.000 title abstract 3
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3020787A | 1987-03-25 | 1987-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN88025A1 true TNSN88025A1 (fr) | 1990-07-10 |
Family
ID=21853062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN88025A TNSN88025A1 (fr) | 1987-03-25 | 1988-03-25 | 4-[4-[4-[4-[[2-(2,4 - difluorophenyl)-2-(1h-azolymethyl) - 1,3 - dioxolanne -4- yl] methoxy phenyl] -1- piperazinyl] phenyl] triazolones. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0283992B1 (en, 2012) |
| JP (1) | JPH0667929B2 (en, 2012) |
| KR (1) | KR960012370B1 (en, 2012) |
| CN (1) | CN1038588C (en, 2012) |
| AT (1) | ATE80626T1 (en, 2012) |
| AU (1) | AU600107B2 (en, 2012) |
| CA (1) | CA1313875C (en, 2012) |
| CY (1) | CY1837A (en, 2012) |
| DE (1) | DE3874576T2 (en, 2012) |
| DK (1) | DK168336B1 (en, 2012) |
| ES (1) | ES2044991T3 (en, 2012) |
| FI (1) | FI89798C (en, 2012) |
| GR (1) | GR3006420T3 (en, 2012) |
| HK (1) | HK50395A (en, 2012) |
| HU (1) | HU204819B (en, 2012) |
| IE (1) | IE61802B1 (en, 2012) |
| IL (1) | IL85823A (en, 2012) |
| MA (1) | MA21227A1 (en, 2012) |
| NO (1) | NO168476C (en, 2012) |
| NZ (1) | NZ223799A (en, 2012) |
| PH (1) | PH25023A (en, 2012) |
| PT (1) | PT87073B (en, 2012) |
| SU (1) | SU1635900A3 (en, 2012) |
| TN (1) | TNSN88025A1 (en, 2012) |
| ZA (1) | ZA882118B (en, 2012) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| US5075309A (en) * | 1989-06-09 | 1991-12-24 | Janssen Pharmaceutica N.V. | Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones |
| NZ233502A (en) * | 1989-06-09 | 1991-11-26 | Janssen Pharmaceutica Nv | 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions |
| WO1993007847A1 (en) * | 1991-10-15 | 1993-04-29 | Kenneth Vincent Mason | Anti-seborrhoeic formulation |
| IL103558A0 (en) * | 1991-10-30 | 1993-03-15 | Schering Corp | Tri-substituted tetrahydrofuran antifungals |
| TW218017B (en, 2012) * | 1992-04-28 | 1993-12-21 | Takeda Pharm Industry Co Ltd | |
| PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
| CN1078210C (zh) * | 1994-01-24 | 2002-01-23 | 詹森药业有限公司 | 水溶性吡咯系杀真菌剂 |
| AU697744C (en) * | 1994-10-27 | 2002-08-22 | Elanco Animal Health Ireland Limited | Apolipoprotein-B synthesis inhibitors |
| US5625064A (en) * | 1995-04-19 | 1997-04-29 | Schering Corporation | Process for the preparation of triazolones |
| TW457240B (en) * | 1995-04-20 | 2001-10-01 | Janssen Pharmaceutica Nv | Novel triazolones as apolipoprotein-B synthesis inhibitors |
| US20050025791A1 (en) | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
| US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| US7446107B2 (en) | 2002-02-15 | 2008-11-04 | Transform Pharmaceuticals, Inc. | Crystalline forms of conazoles and methods of making and using the same |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| AU2003213719A1 (en) | 2002-03-01 | 2003-09-16 | Regents Of The University Of Michigan | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| AU2003243354A1 (en) * | 2002-05-31 | 2003-12-19 | Transform Pharmaceuticals, Inc. | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| EP1742941A1 (en) * | 2004-04-22 | 2007-01-17 | Transform Pharmaceuticals, Inc. | Novel saperconazole crystalline forms and related processes, pharmaceutical compositions and methods |
| MX342850B (es) * | 2010-05-19 | 2016-10-14 | Sandoz Ag | Proceso para la preparacion de triazolonas quirales. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
| US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
| CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
-
1988
- 1988-03-08 NZ NZ223799A patent/NZ223799A/xx unknown
- 1988-03-16 CA CA000561609A patent/CA1313875C/en not_active Expired - Fee Related
- 1988-03-18 KR KR1019880002863A patent/KR960012370B1/ko not_active Expired - Fee Related
- 1988-03-21 EP EP88104473A patent/EP0283992B1/en not_active Expired - Lifetime
- 1988-03-21 AT AT88104473T patent/ATE80626T1/de not_active IP Right Cessation
- 1988-03-21 DE DE8888104473T patent/DE3874576T2/de not_active Expired - Fee Related
- 1988-03-21 ES ES88104473T patent/ES2044991T3/es not_active Expired - Lifetime
- 1988-03-22 MA MA21468A patent/MA21227A1/fr unknown
- 1988-03-23 IL IL85823A patent/IL85823A/xx not_active IP Right Cessation
- 1988-03-24 FI FI881404A patent/FI89798C/fi not_active IP Right Cessation
- 1988-03-24 NO NO881306A patent/NO168476C/no not_active IP Right Cessation
- 1988-03-24 ZA ZA882118A patent/ZA882118B/xx unknown
- 1988-03-24 PT PT87073A patent/PT87073B/pt not_active IP Right Cessation
- 1988-03-24 IE IE89388A patent/IE61802B1/en not_active IP Right Cessation
- 1988-03-24 SU SU884356110A patent/SU1635900A3/ru active
- 1988-03-24 DK DK163288A patent/DK168336B1/da not_active IP Right Cessation
- 1988-03-24 HU HU881508A patent/HU204819B/hu not_active IP Right Cessation
- 1988-03-24 AU AU13585/88A patent/AU600107B2/en not_active Ceased
- 1988-03-25 TN TNTNSN88025A patent/TNSN88025A1/fr unknown
- 1988-03-25 JP JP63069915A patent/JPH0667929B2/ja not_active Expired - Fee Related
- 1988-03-25 CN CN88101660A patent/CN1038588C/zh not_active Expired - Fee Related
- 1988-03-25 PH PH36690A patent/PH25023A/en unknown
-
1992
- 1992-12-02 GR GR920402784T patent/GR3006420T3/el unknown
-
1995
- 1995-04-06 HK HK50395A patent/HK50395A/en not_active IP Right Cessation
- 1995-12-01 CY CY183795A patent/CY1837A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN88025A1 (fr) | 4-[4-[4-[4-[[2-(2,4 - difluorophenyl)-2-(1h-azolymethyl) - 1,3 - dioxolanne -4- yl] methoxy phenyl] -1- piperazinyl] phenyl] triazolones. | |
| CA1280366C (en) | Topical antimicrobial pharmaceutical composition comprising a silver compound and an azole | |
| Honnas et al. | Septic tenosynovitis in horses: 25 cases (1983-1989) | |
| DE60008206D1 (de) | Chinolinderivate verwendbar zur Hemmung der Farnesyl-Protein Transferase | |
| Brown et al. | A novel in vitro assay for anti-inflammatory agents based on stabilization of erythrocytes | |
| TR200201413T2 (tr) | Faktör Xa' nın inhibitörleri. | |
| MA21446A1 (fr) | Nouveaux derives de pyridazinamine et procede de destruction de virus ou de prevention contre leur developpement chez les animaux a sang chaud, composition antivirale en comportant application ainsi que leur procede de preparation. | |
| GR81149B (en) | Growth promotants for animals | |
| NO922147L (no) | Heterocykliske derivater | |
| BR9814124A (pt) | Inibidores de aminotiazol de cinases dependentes de ciclina | |
| DK0664126T3 (da) | Hæmning af trombin | |
| JPS6425777A (en) | Organic salt of physostigmine | |
| DK517588A (da) | L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK350386D0 (da) | Baktericide praeparater til anvendelse indenfor det veterinaermedicinske omraade | |
| EA003458B1 (ru) | Усиление активности оксазолидиноновых антибактериальных агентов в результате применения производных аргинина | |
| DK616388A (da) | Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning | |
| PT78041B (fr) | Procede de preparation de sels de derives organophosphores fongicides et de compositions fongicides et/ou bactericides les contenant | |
| MA21379A1 (fr) | Derives de (benzyl-piperidine)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant. | |
| PL294701A1 (en, 2012) | ||
| MA27056A1 (fr) | Derives d'azolylcarbinols d'aryle (ou d'heteroaryle) pour le traitement de l'incontinence d'urine. | |
| BR9916466A (pt) | Compostos de organofósforo e seu uso | |
| CA2415900A1 (en) | Uses for nad synthetase inhibitors | |
| FR2637596B1 (fr) | Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant | |
| EP0439450B1 (en) | Pharmaceutical composition | |
| ID22543A (id) | Senyawa karbapenem, penggunaan dan senyawa antaranya |